Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The kinase inhibitor delayed disease progression by 27% for people who had tried at least two prior therapies.
First-line Lenvima plus Keytruda yields better overall survival for patients with metastatic kidney cancer.
The immunotherapy combination slowed disease progression and reduced the risk of death by 40%.
Metastatic kidney cancer patients with greater microbial diversity had better outcomes with immunotherapy.
Through her sculptures, Shelley Kerr describes the battle, journey and gratitude of living with stage IV bladder cancer.
These cancers include those that are rare among adults under 40, such as breast, colon, pancreas, kidney, prostate and ovarian cancer.
A survey of people with kidney cancer reveals that they fear both COVID-19 and cancer progression equally.
If you are experiencing back pain in conjunction with other symptoms, contact your primary health doctor.
Genitourinary Cancers Symposium reaches beyond the latest prostate, bladder and kidney cancer treatments.
MK-6482 shrank tumors in 24% of people with advanced renal cell carcinoma.
Mark Ruffalo stars as a lawyer who takes on a chemical giant in this movie inspired by real events.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.